Reimbursement, Not Off-Label Use, May Be Hindering Carotid Stent Trials
This article was originally published in The Gray Sheet
Executive Summary
Enrollment of randomized trials of carotid stents in low-risk patients has been slow because many doctors have an economic incentive to prevent their patients from being randomized, according to Kenneth Rosenfield, M.D., Massachusetts General Hospital